drugset / Trial / NCT03716024
Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
RandomizedParallel-groupTriple-blindTreatment
Summary
A Phase II trial to demonstrate the safety and efficacy of PTK 0796 in the treatment of complicated skin and skin structure infections (cSSSI).
Timeline
- Start
- 2007-07-18
- Primary completion
- 2008-01-07
- Completion
- 2008-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linezolid | Other / unclassified | 600 mg | Intravenous |
| Subject | Omadacycline | Small molecule | 100 mg | Intravenous |